Eduardo Iturrate

Dr. Eduardo Iturrate


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2020 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
HRHarmony R. Reynolds
Harmony R. Reynolds
SASamrachana Adhikari
Samrachana Adhikari
CPClaudia Pulgarin
Claudia Pulgarin
ATAndrea B. Troxel
Andrea B. Troxel
EIEduardo Iturrate
Eduardo Iturrate
JHJudith S. Hochman
Judith S. Hochman
There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). We assessed the relation between previous treatment with ACE inhibitors, angiotensin-receptor blockers, beta-blockers, calcium-channel blockers, or thiazide diuretics and the likelihood of a positive or negative result on Covid-19 testing as well as the likelihood of severe illness (defined as intensive care, mechanical ventilation, or death) among patients who tested positive. Using Bayesian methods, we compared outcomes in patients who had been treated with these medications and in untreated patients, overall and in those with hypertension, after propensity-score matching for receipt of each medication class. A difference of at least 10 percentage points was prespecified as a substantial difference. Among 12,594 patients who were tested for Covid-19, a total of 5894 (46.8%) were positive; 1002 of these patients (17.0%) had severe illness. A history of hypertension was present in 4357 patients (34.6%), among whom 2573 (59.1%) had a positive test; 634 of these patients (24.6%) had severe illness. There was no association between any single medication class and an increased likelihood of a positive test. None of the medications examined was associated with a substantial increase in the risk of severe illness among patients who tested positive. We found no substantial increase in the likelihood of a positive test for Covid-19 or in the risk of severe Covid-19 among patients who tested positive in association with five common classes of antihypertensive medications.

20 July 2020 in JAMA
Verified
Journal Article
Open access
PDF file
SBSeda Bilaloglu
Seda Bilaloglu
YAYin Aphinyanaphongs
Yin Aphinyanaphongs
SJSimon Jones
Simon Jones
EIEduardo Iturrate
Eduardo Iturrate
JHJudith Hochman
Judith Hochman
JBJeffrey S. Berger
Jeffrey S. Berger
Patients with coronavirus disease 2019 (COVID-19) are at increased risk of thrombosis.1 However, studies have been limited in size, did not report all thrombotic events, and focused on patients with severe disease hospitalized in intensive care units (ICUs). We assessed the incidence of, and risk factors for, venous and arterial thrombotic events in all hospitalized patients with COVID-19 at a large health system consisting of 4 hospitals in New York City.

30 June 2015 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
BWBenjamin Wertheimer
Benjamin Wertheimer
RJRamon E. A. Jacobs
Ramon E. A. Jacobs
EIEduardo Iturrate
Eduardo Iturrate
MBMartha Bailey
Martha Bailey
KHKatherine Hochman
Katherine Hochman

1 November 2019 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
SKStella K. Kang
Stella K. Kang
KGKira Garry
Kira Garry
RCRyan Chung
Ryan Chung
WMWilliam H. Moore
William H. Moore
EIEduardo Iturrate
Eduardo Iturrate
SBSaul Blecker
Saul Blecker

17 May 2023 in Perspectives on Medical Education
Verified
Journal Article
Open access
PDF file
JBJesse Burk-Rafel
Jesse Burk-Rafel
SSStefanie S. Sebok-Syer
Stefanie S. Sebok-Syer
SSSally A. Santen
Sally A. Santen
JJJoshua Jiang
Joshua Jiang
HCHolly A. Caretta-Weyer
Holly A. Caretta-Weyer
BKBenjamin Kinnear
Benjamin Kinnear
Competency-based medical education (CBME) is an outcomes-based approach to education and assessment that focuses on what competencies trainees need to learn in order to provide effective patient care. Despite this goal of providing quality patient care, trainees rarely receive measures of their clinical performance. This is problematic because defining a trainee’s learning progression requires measuring their clinical performance. Traditional clinical performance measures (CPMs) are often met with skepticism from trainees given their poor individual-level attribution. Resident-sensitive quality measures (RSQMs) are attributable to individuals, but lack the expeditiousness needed to deliver timely feedback and can be difficult to automate at scale across programs. In this eye opener, the authors present a conceptual framework for a new type of measure – TRainee Attributable & Automatable Care Evaluations in Real-time (TRACERs) – attuned to both automation and trainee attribution as the next evolutionary step in linking education to patient care. TRACERs have five defining characteristics: meaningful (for patient care and trainees), attributable (sufficiently to the trainee of interest), automatable (minimal human input once fully implemented), scalable (across electronic health records [EHRs] and training environments), and real-time (amenable to formative educational feedback loops). Ideally, TRACERs optimize all five characteristics to the greatest degree possible. TRACERs are uniquely focused on measures of clinical performance that are captured in the EHR, whether routinely collected or generated using sophisticated analytics, and are intended to complement (not replace) other sources of assessment data. TRACERs have the potential to contribute to a national system of high-density, trainee-attributable, patient-centered outcome measures.

1 May 2017 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
JSJordan Swartz
Jordan Swartz
CKChristian Koziatek
Christian Koziatek
JTJason Theobald
Jason Theobald
SSSilas Smith
Silas Smith
EIEduardo Iturrate
Eduardo Iturrate